Skip to content

Cannabis: all studies

Page 277 of 287: studies 2,761 to 2,770 of 2,864, newest first. Back to the cannabis overview

Research

Chronic MDMA (ecstasy) use, cognition and mood.

Psychopharmacology May 2004 K McCardle, S Luebbers, J D Carter et al.

It has been suggested that 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) causes damage to the serotonergic system, and that this damage results in cognitive and mood impairments. To examine the effect of chronic MDMA usage on a wide battery of cognitive tests and psychological abilities and processes. In the present study, the performance of 17 participants with a history of MDMA use was...

Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

Proceedings of the National Academy of Sciences of the United States of America February 3, 2004 Attila Losonczy, Agota A Biró, Zoltan Nusser

Cortical information processing requires an orchestrated interaction between a large number of pyramidal cells and albeit fewer, but highly diverse GABAergic interneurons (INs). The diversity of INs is thought to reflect functional and structural specializations evolved to control distinct network operations. Consequently, specific cortical functions may be selectively modified by altering the...

Prenatal cannabinoid exposure down- regulates glutamate transporter expressions (GLAST and EAAC1) in the rat cerebellum.

Developmental Neuroscience 2004 I Suárez, G Bodega, M Rubio et al.

Efficient reuptake of synaptically released glutamate is essential for preventing glutamate receptor overstimulation and neuronal death. Glutamate transporters play a vital role in removing extracellular glutamate from the synaptic cleft. This study analyzed the expression of the glial (GLAST) and neuronal (EAAC1) subtypes of glutamate transporter in the cerebellum of male and female offspring...

Depersonalisation disorder: a contemporary overview.

CNS Drugs 2004 Daphne Simeon

Depersonalisation disorder is characterised by prominent depersonalisation and often derealisation, without clinically notable memory or identity disturbances. The disorder has an approximately 1 : 1 gender ratio with onset at around 16 years of age. The course of the disorder is typically long term and often continuous. Mood, anxiety and personality disorders are often comorbid with...

Role of endocannabinoid system in mental diseases.

Neurotoxicity Research 2004 Jorge Manzanares, Leyre Urigüen, Gabriel Rubio et al.

In the last decade, a large number of studies using Delta9-tetrahydrocannabinol (THC), the main active principle derivative of the marijuana plant, or cannabinoid synthetic derivatives have substantially contributed to advance the understanding of the pharmacology and neurobiological mechanisms produced by cannabinoid receptor activation. Cannabis has been historically used to relieve some of...

Office of National Drug Control Policy

Encyclopedia of Law Enforcement 2004 418 citations

This Pulse Check is a report of national trends in illicit drug abuse and drug markets in the United States. The report draws on conversations with ethnographers and epidemiologists working in the drug field, law enforcement agents, and drug treatment providers across the United States. Information from each of these sources is summarized in narrative form broken down by drug type and presented...

DOI: 10.4135/9781412952415.n342 (opens in new tab) Drug control Control management Public administration Pharmacology +1

Applying an Extended Version of the Theory of Planned Behavior to Illicit Drug Use Among Students1

Journal of Applied Social Psychology August 1, 2003 Brian Mcmillan, Mark Conner 163 citations

This study employed the theory of planned behavior (TPB) to investigate the factors underlying intentions to use and use of LSD, amphetamine, cannabis, and ecstasy over 6 months in a sample of students ( N = 461). The TPB provided good predictions of both intentions (mean R 2 = .49) and behavior (mean R 2 = .45). Descriptive norms explained additional variance in intentions for all the drugs,...

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.

Synapse July 2003 Christopher D. Verrico, J David Jentsch, Robert H Roth

Long-term abuse of delta-9-tetrahydrocannabinol (THC), the major psychoactive constituent of marijuana, produces behavioral and metabolic signs of frontal cortical dysfunction in humans; these effects persist even after short-term abstinence. Based on a preliminary finding that repeated administration of THC to rats reduces basal frontal cortical dopamine turnover (Jentsch et al. [1998]...

The road of excess: a history of writers on drugs

Choice Reviews Online July 1, 2003 148 citations

Prologue 1. Addicted to Nothingness: Narcotics and Literature 2. The Voice of the Blood: Transcendentalism and Anesthetic Revelation 3. The Time of the Assassins: Cannabis and Literature 4. Induced Life: Stimulants and Literature 5. The Imaginal Realms: Psychedelics and Literature Epilogue Bibliography Notes Acknowledgments Illustration Credits Index

Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.

Journal of Neuroscience June 15, 2003 Alexander F. Hoffman, Murat Oz, Tara Caulder et al.

The rewarding properties of the psychoactive constituents of marijuana, termed "cannabinoids," may reflect actions on synaptic transmission in the nucleus accumbens (NAc). Furthermore, long-term changes in these synapses may support the addictive process. Excitatory and inhibitory synapses are acutely inhibited by cannabinoids in the NAc, and endogenous cannabinoids (endocannabinoids) play a...